An Open-Label Phase II Trial of the Combination of Decitabine, SQ Bortezomib and Pegylated Liposomal Doxorubicin for the Treatment of Patients with Relapsed/Refractory Acute Myelogenous Leukemia

被引:0
作者
Potter, Laura A. [1 ]
Galkin, Maria [2 ]
Rosenberg, Aaron S. [3 ]
Hoeg, Rasmus T. [3 ]
Abedi, Mehrdad [3 ]
Tuscano, Joseph M. [3 ]
Jonas, Brian A. [3 ]
机构
[1] Univ Calif, Davis Sch Med, Sacramento, CA USA
[2] Tufts Med Ctr, Div Hematol Oncol, Dept Med, Boston, MA USA
[3] Univ Calif, Div Hematol & Oncol, Dept Internal Med, Davis Sch Med, Sacramento, CA USA
关键词
D O I
10.1182/blood-202147349
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2352
引用
收藏
页数:4
相关论文
empty
未找到相关数据